These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 16527016

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The use of botulinum toxin type A in aesthetic mandibular contouring.
    Kim NH, Chung JH, Park RH, Park JB.
    Plast Reconstr Surg; 2005 Mar; 115(3):919-30. PubMed ID: 15731696
    [Abstract] [Full Text] [Related]

  • 3. Effects of botulinum toxin type A on contouring of the lower face.
    Choe SW, Cho WI, Lee CK, Seo SJ.
    Dermatol Surg; 2005 May; 31(5):502-7; discussion 507-8. PubMed ID: 15962731
    [Abstract] [Full Text] [Related]

  • 4. Effects of botulinum toxin type A on bilateral masseteric hypertrophy evaluated with computed tomographic measurement.
    Kim HJ, Yum KW, Lee SS, Heo MS, Seo K.
    Dermatol Surg; 2003 May; 29(5):484-9. PubMed ID: 12752515
    [Abstract] [Full Text] [Related]

  • 5. Botulinum toxin for masseter hypertrophy.
    Al-Muharraqi MA, Fedorowicz Z, Al Bareeq J, Al Bareeq R, Nasser M.
    Cochrane Database Syst Rev; 2009 Jan 21; (1):CD007510. PubMed ID: 19160335
    [Abstract] [Full Text] [Related]

  • 6. The change of maximum bite force after botulinum toxin type a injection for treating masseteric hypertrophy.
    Ahn KY, Kim ST.
    Plast Reconstr Surg; 2007 Nov 21; 120(6):1662-1666. PubMed ID: 18040203
    [Abstract] [Full Text] [Related]

  • 7. The medical management of masseteric hypertrophy with botulinum toxin.
    Finn S, Ryan P, Sleeman D.
    J Ir Dent Assoc; 2000 Nov 21; 46(3):84-6. PubMed ID: 11323940
    [Abstract] [Full Text] [Related]

  • 8. Botulinum toxin for masseter hypertrophy.
    Fedorowicz Z, van Zuuren EJ, Schoones J.
    Cochrane Database Syst Rev; 2013 Sep 09; 2013(9):CD007510. PubMed ID: 24018587
    [Abstract] [Full Text] [Related]

  • 9. Treatment of unilateral masseteric hypertrophy with botulinum toxin: case report.
    Mandel L, Tharakan M.
    J Oral Maxillofac Surg; 1999 Aug 09; 57(8):1017-9. PubMed ID: 10437733
    [No Abstract] [Full Text] [Related]

  • 10. Botulinum toxin type A treatment for contouring of the lower face.
    Park MY, Ahn KY, Jung DS.
    Dermatol Surg; 2003 May 09; 29(5):477-83; discussion 483. PubMed ID: 12752514
    [Abstract] [Full Text] [Related]

  • 11. Discussion on The risorius muscle: anatomic considerations with reference to botulinum neurotoxin injection for masseteric hypertrophy.
    Hwang K.
    Dermatol Surg; 2014 Dec 09; 40(12):1340-1. PubMed ID: 25380090
    [No Abstract] [Full Text] [Related]

  • 12. Classification of masseter hypertrophy for tailored botulinum toxin type A treatment.
    Xie Y, Zhou J, Li H, Cheng C, Herrler T, Li Q.
    Plast Reconstr Surg; 2014 Aug 09; 134(2):209e-218e. PubMed ID: 25068343
    [Abstract] [Full Text] [Related]

  • 13. Abobotulinum toxin A and onabotulinum toxin A for masseteric hypertrophy: a split-face study in 25 Korean patients.
    Lee SH, Wee SH, Kim HJ, Yeo UC, Lee NH, Lee SW, Cho SB.
    J Dermatolog Treat; 2013 Apr 09; 24(2):133-6. PubMed ID: 21888570
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of incobotulinum toxin A in periocular rhytides and masseteric hypertrophy: side-by-side comparison with onabotulinum toxin A.
    Lee JH, Park JH, Lee SK, Han KH, Kim SD, Yoon CS, Park JY, Lee JH, Yang JM, Lee JH.
    J Dermatolog Treat; 2014 Aug 09; 25(4):326-30. PubMed ID: 23356833
    [Abstract] [Full Text] [Related]

  • 15. Treatment of masseteric hypertrophy with botulinum toxin: a report of two cases.
    Baş B, Ozan B, Muğlali M, Celebi N.
    Med Oral Patol Oral Cir Bucal; 2010 Jul 01; 15(4):e649-52. PubMed ID: 20173718
    [Abstract] [Full Text] [Related]

  • 16. Bilateral hypertrophy of masseteric and temporalis muscles, our fifteen patients and review of literature.
    Graziano P, Dell'Aversana Orabona G, Astarita F, Ponzo LM, Nunziata R, Salzano G, Maglitto F, Solari D, Santella A, Cappabianca M, Iaconetta G, Califano L.
    Eur Rev Med Pharmacol Sci; 2016 Jul 01; 20(1):7-11. PubMed ID: 26813447
    [Abstract] [Full Text] [Related]

  • 17. A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement.
    To EW, Ahuja AT, Ho WS, King WW, Wong WK, Pang PC, Hui AC.
    Br J Plast Surg; 2001 Apr 01; 54(3):197-200. PubMed ID: 11254408
    [Abstract] [Full Text] [Related]

  • 18. Evaluation and selecting indications for the treatment of improving facial morphology by masseteric injection of botulinum toxin type A.
    Gaofeng L, Jun T, Bo P, Bosheng Z, Qian Z, Dongping L.
    J Plast Reconstr Aesthet Surg; 2010 Dec 01; 63(12):2026-31. PubMed ID: 20116356
    [Abstract] [Full Text] [Related]

  • 19. The topographic anatomy of the masseteric nerve: A cadaveric study with an emphasis on the effective zone of botulinum toxin A injections in masseter.
    Kaya B, Apaydin N, Loukas M, Tubbs RS.
    J Plast Reconstr Aesthet Surg; 2014 Dec 01; 67(12):1663-8. PubMed ID: 25175271
    [Abstract] [Full Text] [Related]

  • 20. Nonsurgical reshaping of the lower face.
    Liew S, Dart A.
    Aesthet Surg J; 2008 Dec 01; 28(3):251-7. PubMed ID: 19083534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.